Market Place
Sourcing Support
OTEZLA Now Available In US For Pediatric Plaque Psoriasis
20 Aug 2024 //
PR NEWSWIRE
AMGEN ANNOUNCES 2024 THIRD QUARTER DIVIDEND
02 Aug 2024 //
PR NEWSWIRE
Amgen 1Q Results
21 May 2024 //
CONTRACT PHARMA
Amgen Presents New Research On Otezla® (Apremilast) At Aad 2024
09 Mar 2024 //
PR NEWSWIRE
Mankind Pharma`s Generic Apremilast Receives Approval in the U.S.
07 Feb 2024 //
FDA
Apopharma`s Generic Apremilast Receives Approval in the U.S.
24 Jan 2024 //
FDA
SKYRIZI Achieved Superiority Versus Apremilast for Co-Primary Endpoints
26 Jul 2023 //
PR NEWSWIRE
AMGEN WINS PATENT APPEAL ON OTEZLA® (APREMILAST)
19 Apr 2023 //
PR NEWSWIRE
Shilpa`s Generic Apremilast Receives Approval in the U.S.
07 Apr 2023 //
FDA
Tiefenbacher Successfully Launches Generic Version Of The Psoriasis Apremilast
01 Dec 2022 //
PRESS RELEASE
U.S. Food and Drug Administration Approves Sotyktu
09 Sep 2022 //
BUSINESSWIRE
Amgen Announces Positive New Data At Eadv 2022 For Otezla® (Apremilast)
08 Sep 2022 //
PRNEWSWIRE
Teva`s Generic Apremilast Receives Approval in the U.S.
18 Aug 2022 //
FDA
Zydus Pharms` Generic Apremilast Receives Approval in the U.S.
03 Feb 2022 //
FDA
Zydus Pharms` Generic Apremilast Receives Approval in the U.S.
03 Feb 2022 //
FDA
US FDA approves expanded use of Amgen’s psoriasis drug
21 Dec 2021 //
EXPRESSPHARMA
FDA approves Otezla (apremilast) for the treatment of adult patients with plaque
20 Dec 2021 //
AMGEN
FDA APPROVES OTEZLA FOR THE TREATMENT OF PLAQUE PSORIASIS
20 Dec 2021 //
PRNEWSWIRE
Amgen announces positive top-line results from Otezla phase-III
02 Dec 2021 //
EXPRESS PHARMA
Amgen Announces Positive Top-Line Results From Otezla Phase 3 DISCREET Study
01 Dec 2021 //
PRNEWSWIRE
BMS’ new JAK inhibitor enters regulatory pathways
01 Dec 2021 //
PMLIVE
Zydus Cadila gets US FDA marketing approval for apremilast tablets
24 Sep 2021 //
PHARMABIZ
Amgen scores Otezla patent win, nabbing protection until 2028
22 Sep 2021 //
FIERCEPHARMA
Alkem Labs`s Generic Apremilast Receives Approval In US
21 Sep 2021 //
FDA
Zydus Pharms`s Generic Apremilast Receives Approval In US
21 Sep 2021 //
FDA
Amgen Wins Patent Case on Otezla® (apremilast)
20 Sep 2021 //
PRNEWSWIRE
FDA Accepts Amgen`s Supplemental New Drug Application For Otezla®
05 May 2021 //
PHARMIWEB
FDA Accepts Amgen`s Supplemental New Drug Application For Otezla® (apremilast)
05 May 2021 //
PRNEWSWIRE
Otezla`s pressures reflected in Amgen`s 1st quarter earnings
29 Apr 2021 //
FIERCE PHARMA
Bristol Myers’ deucravacitinib beats out exiled Otezla
23 Apr 2021 //
FIERCEBIOTECH
OTEZLA® (apremilast) Significantly Improved Measures Of Disease Severity
23 Apr 2021 //
PRNEWSWIRE
Shilpa Medicare gets tentative American health regulator nod for Apremilast tab
05 Mar 2021 //
ECONOMIC TIMES
Amgen Submits Supplemental New Drug Application for Otezla®
23 Feb 2021 //
PRNEWSWIRE
Amgen lines up expansion to Otezla`s $13B franchise; China OKs `breakthrough`
23 Feb 2021 //
ENDPTS
Amgen Submits Supplemental New Drug Application for Otezla®
22 Feb 2021 //
PRNEWSWIRE
Unichem Labs zooms 6% on USFDA approval for Apremilast tablets
20 Feb 2021 //
THEHINDUBUSINESSLINE
Moderna taps Amgen`s Le Goff as commercial exec as vaccine rolls
09 Jan 2021 //
FIERCE PHARMA
Amgen hands off rights to leprosy, tuberculosis med picked up $13.4B Otezla deal
24 Dec 2020 //
ENDPTS
Bristol Myers posts another win for their Otezla competitor, this time PhII data
11 Nov 2020 //
ENDPTS
AbbVie`s Skyrizi stands to gain as docs move away from older psoriasis meds
25 Aug 2020 //
FIERCEPHARMA
AbbVie, Amgen and Takeda repurpose drugs in joint COVID-19 study
04 Aug 2020 //
FIERCE PHARMA
Big pharma alliance recruits first patients for unusual COVID-19 study
03 Aug 2020 //
BIOPHARMADIVE
MSN Pharma Generic Apremilast Receives Tentative Approval In US
31 Jul 2020 //
FDA
Amgen`s psoriasis pill Otezla thrives amid pandemic
29 Jul 2020 //
FIERCE PHARMA
Sandoz`s Generic Apremilast Receives Approval in U.S
29 Jul 2020 //
FDA
Amgen Is Supporting Advancement Of AMG 634 For Global Health Diseases
23 Jun 2020 //
PRNEWSWIRE
Amgen Is Supporting Advancement Of AMG 634 For Global Health Disease
22 Jun 2020 //
PRESS RELEASE
Amgen Announces Positive Top-Line Results From Otezla® (apremilast)
07 May 2020 //
PRNEWSWIRE
Amgen adds Otezla to the COVID-19 candidate list
05 May 2020 //
PMLIVE
CHMP Recommends One New Drug, Begins Review of Indian CRO
29 Feb 2020 //
RAPS
Amgen says launches, biosims will drive growth after down year
31 Jan 2020 //
FIERCE PHARMA
After FTC surprises, pharma should expect more M&A scrutiny in 2020
21 Dec 2019 //
FIERCE PHARMA
Can-Fite Completes 50% Patient Enrollment in its Phase III Psoriasis Trial
09 Dec 2019 //
BUSINESSWIRE
Phathom Pharmaceuticals Expands Leadership Team and Announces Board Transition
02 Dec 2019 //
BUSINESS WIRE
Vifor Pharma Appoints Lee Heeson as President International and Member
18 Nov 2019 //
BUSINESS WIRE
Zydus Cadila gets tentative USFDA approval to market arthritis drug
18 Nov 2019 //
BUSINESS STANDARD
Another big biopharma merger runs into another snag at the FTC. What now?
28 Sep 2019 //
ENDPTS
Roche and Spark Continue to See Delays for Pending Deal
07 Sep 2019 //
BIOSPACE
Alexion investors sucker-punched as PTO takes up Soliris patent challenge
30 Aug 2019 //
FIERCE PHARMA
